The Semaglutide Treatment Effect in People with Obesity (STEP) trials showed 12%-15% weight loss with semaglutide, less in type 2 diabetes patients
Juliette Cubanski, vice president and director of Medicare policy at KFF, put it plainly to CBS News: "In the short term, we have this temporary program, and then no clear path forward yet as to what will happen at the end of 2027." CMS Administrator Mehmet Oz framed the Bridge as a stopgap at launch, according to AJMC, but has not indicated when or whether a permanent mechanism will follow
Or not at all
Period changes during semaglutide are typically temporary and tied to weight loss and metabolic adjustment
Current Pharmaceutical Design, 2014, 20(7):1121-1125 2.Sikiric P, Seiwerth S, Brcic L, Sever M, Klicek R, Radic B, Drmic D, Ilic S, Kolenc D
A short overview can help reinforce the habits that make maintenance work: Keep the lifestyle pillars active Medication can quiet hunger